Literature DB >> 11953347

Approaches to uninvestigated dyspepsia.

R H Jones1.   

Abstract

Uninvestigated dyspepsia refers to patients with new or recurrent dyspeptic symptoms in whom no investigations have previously been undertaken. These patients are much more likely to present in primary than in secondary care. It is particularly important to be able to offer effective symptom relief to support the explanation, reassurance, and advice provided to patients, and low dose or standard dose proton pump inhibitor therapy appears to offer the most effective approach to empirical therapy of this kind.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11953347      PMCID: PMC1867704          DOI: 10.1136/gut.50.suppl_4.iv42

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  12 in total

1.  Low-dose lansoprazole provides greater relief of heartburn and epigastric pain than low-dose omeprazole in patients with acid-related dyspepsia.

Authors:  R Jones; S L Crouch
Journal:  Aliment Pharmacol Ther       Date:  1999-03       Impact factor: 8.171

2.  Factors affecting the decision to consult with dyspepsia: comparison of consulters and non-consulters.

Authors:  S Lydeard; R Jones
Journal:  J R Coll Gen Pract       Date:  1989-12

3.  A trial of a test-and-treat strategy for Helicobacter pylori positive dyspeptic patients in general practice.

Authors:  R Jones; C Tait; G Sladen; J Weston-Baker
Journal:  Int J Clin Pract       Date:  1999-09       Impact factor: 2.503

4.  The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected].

Authors:  I Mason; L J Millar; R R Sheikh; W M Evans; P L Todd; M L Turbitt; M D Taylor
Journal:  Aliment Pharmacol Ther       Date:  1998-03       Impact factor: 8.171

Review 5.  Self-care and primary care of dyspepsia: a review.

Authors:  R Jones
Journal:  Fam Pract       Date:  1987-03       Impact factor: 2.267

6.  Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice.

Authors:  R H Jones; G Baxter
Journal:  Aliment Pharmacol Ther       Date:  1997-06       Impact factor: 8.171

7.  Use of H2-receptor antagonists in patients with dyspepsia and heartburn: a cost comparison.

Authors:  K J Goulston; O F Dent; A Mant; J Logan; M Ngu
Journal:  Med J Aust       Date:  1991-07-01       Impact factor: 7.738

8.  Prospective screening of dyspeptic patients by Helicobacter pylori serology.

Authors:  P Patel; S Khulusi; M A Mendall; R Lloyd; R Jazrawi; J D Maxwell; T C Northfield
Journal:  Lancet       Date:  1995-11-18       Impact factor: 79.321

9.  Dyspepsia in England and Scotland.

Authors:  R H Jones; S E Lydeard; F D Hobbs; J E Kenkre; E I Williams; S J Jones; J A Repper; J L Caldow; W M Dunwoodie; J M Bottomley
Journal:  Gut       Date:  1990-04       Impact factor: 23.059

10.  Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia.

Authors:  P Bytzer; J M Hansen; O B Schaffalitzky de Muckadell
Journal:  Lancet       Date:  1994-04-02       Impact factor: 79.321

View more
  6 in total

1.  Functional dyspepsia.

Authors:  Rita Brun; Braden Kuo
Journal:  Therap Adv Gastroenterol       Date:  2010-05       Impact factor: 4.409

2.  Gallstone disease founded by ultrasonography in functional dyspepsia: prevalence and associated factors.

Authors:  Yaser Froutan; Ahmad Alizadeh; Fariborz Mansour-Ghanaei; Farahnaz Joukar; Hossein Froutan; Faeze Berenji Bagheri; Mohammad Reza Naghipour; Seyed Ali Chavoshi
Journal:  Int J Clin Exp Med       Date:  2015-07-15

3.  Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia.

Authors:  Masahiro Sakaguchi; Miyuki Takao; Yasuo Ohyama; Hiroshi Oka; Hiroshi Yamashita; Takumi Fukuchi; Kiyoshi Ashida; Masahiro Murotani; Masuyo Murotani; Kazuo Majima; Hiroshi Morikawa; Takashi Hashimoto; Keisuke Kiyota; Hirohiko Esaki; Kanji Amemoto; Gouhei Isowa; Fumiyuki Takao
Journal:  World J Gastroenterol       Date:  2012-04-07       Impact factor: 5.742

4.  Prevalence of gastroesophageal reflux disease symptoms and uninvestigated dyspepsia in Korea: a population-based study.

Authors:  Sun Young Yang; Oh Young Lee; Young Tae Bak; Dae Won Jun; Sang Pyo Lee; Sung Hee Lee; Geun Tae Park; Byung Chul Yoon; Ho Soon Choi; Jun Soo Hahm; Min Ho Lee; Dong Hoo Lee
Journal:  Dig Dis Sci       Date:  2007-05-18       Impact factor: 3.199

5.  Effect of Apium graveolens and Trachyspermum copticom on clinical symptoms of patients with functional dyspepsia.

Authors:  Maryam Azimi; Mohammad Javad Zahedi; Mitra Mehrabani; Haleh Tajadini; Farzaneh Zolala; Mohammad Reza Baneshi; Rasool Choopani; Fariba Sharififar; Ali Asadipour; Mohammad Mahdi Hayatbakhsh; Bijan Ahmadi
Journal:  Avicenna J Phytomed       Date:  2017 Nov-Dec

6.  Effectiveness of Ayurveda treatment in Urdhwaga Amlapitta: A clinical evaluation.

Authors:  Khapre Meenakshi; Nautiyal Vinteshwari; Jagzape Minaxi; Saxena Vartika
Journal:  J Ayurveda Integr Med       Date:  2021-02-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.